All News

    Tevimbra Plus Chemo May Be Safe, Effective in Advanced Gastric/GEJ Cancer

    February 3rd 2025, 10:00pm

    Article

    Frontline treatment with Tevimbra plus irinotecan, paclitaxel, oxaliplatin and 5-FU/leucovorin had promising efficacy and manageable safety in gastric/GEJ cancer.

    Rybrevant Alone and in Combo With Chemo is Efficacious in Wildtype+ mCRC

    February 3rd 2025, 8:00pm

    Article

    Dr. Filippo Pietrantonio discusses OrigAMI-1 trial data which assessed Rybrevant in mutated, wild-type, non-HER2-amplified metastatic colorectal cancer.

    Breast Cancer Sucks But Sometimes Thoughtfulness Can Make It Better

    February 3rd 2025, 6:00pm

    Article

    Breast cancer affected my looks and self-esteem, but I found small things could make a big difference in feeling pretty again.

    Breaking Down Cancer Therapies Approved by the FDA in January 2025

    February 3rd 2025, 4:00pm

    Article

    Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations like AML, MDS and breast cancer.

    Cabometyx Demonstrates PFS Benefit Versus Placebo in GI-NETs

    February 3rd 2025, 2:00pm

    Video

    Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced gastrointestinal NETs.

    ITM-11 Meets Phase 3 Trial Primary End Point of PFS in GEP-NETs

    February 2nd 2025, 7:00pm

    Article

    Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive grade 1 or grade 2 GEP-NETs.

    The Tap on the Shoulder: Cancer's Unexpected Call

    February 1st 2025, 7:00pm

    Article

    After a second breast cancer diagnosis at 61, I faced 17 rounds of chemo, surgery and radiation, changing my perspective on life and leading to a new normal.

    Tevimbra Plus Chemotherapy May Improve Survival in First-Line ESCC

    February 1st 2025, 3:00pm

    Article

    Early and late responders with esophageal squamous cell carcinoma experienced comparable OS benefits with Tevimbra plus chemo in the RATIONALE-306 trial.

    New Trial to Test Light Therapy Plus Keytruda in Head and Neck Cancer

    January 31st 2025, 10:00pm

    Article

    A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck squamous cell carcinoma.

    Breaking Down the Safety of BCG in Patients With NMIBC

    January 31st 2025, 8:00pm

    Article

    BCG therapy is associated with a high frequency of side effects in NMIBC; however, when used in sequential combination with chemo, fewer were reported.